A top Wall Street analyst warns that more biotech cuts are coming as funding tumbles to start 2023
After some signs of growth in late 2022, funding is down in 2023.It's a not so happy new year. At least for the biotech sector.
Last month, companies in the sector raised just $3 billion from investors — down 22% from the $3.9 billion that they raised in the same period a year ago. This comes after some"glimpses of strength" in the second half of last year.They added that many biotech companies have pulled back their ambitions and cut their spending to preserve cash.
Amid the difficult market, the analysts said that they were seeing companies try to save on cash in three ways: by shrinking programs to have fewer data points or target fewer illnesses, pausing research on potential molecules for development, and cutting staff.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Microsoft AI search updates can help boost stock 16%: JefferiesAI updates from Microsoft are the 'tip of the iceberg' of the tech giant's capabilities and the stock can drive up another 16%, says Jefferies
続きを読む »
A Biotech Company Is Working To Save The BeesHow does a special nutrient-packed formula designed to save the bees boost their immune systems and make them stronger in colder temperatures?
続きを読む »
Exclusive: Feng Zhang biotech Aera hires Alnylam leaders as CEO, chairInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
続きを読む »
Walgreens buys Medly's patient data for $19 million in bankruptcy saleInsider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
続きを読む »
Google enlisting staff to test ChatGPT rival Bard: reportAlphabet CEO Sundar Pichai said he will be 'enlisting every Googler' to help test Bard, its new ChatGPT rival, report says
続きを読む »
Leo DiCaprio and Eden Polani’s ‘romance’: Insider reveals the truthA source close to the 48-year-old “Don’t Look Up” actor and Polani shared details with The Post.
続きを読む »